News Focus
News Focus
Post# of 257433
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: BioCocktail post# 233575

Wednesday, 12/21/2022 10:45:14 AM

Wednesday, December 21, 2022 10:45:14 AM

Post# of 257433
CYAD—(-38%)—axes allogeneic CAR-T for MM, which was the company's only clinical program:

https://finance.yahoo.com/news/celyad-oncology-provides-strategic-business-060000281.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today